Evercore ISI has adjusted its price target for MetLife (MET) to $95, down from $97, while maintaining an “In Line” rating on the stock. This update reflects a re-evaluation by the analyst firm, following recent financial presentations and other analyst revisions for the insurance giant. The article also notes other recent analyst actions on MetLife, indicating active re-assessment of the company’s valuation.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Evercore ISI Adjusts Price Target on MetLife to $95 From $97, Maintains In Line Rating
Evercore ISI has adjusted its price target for MetLife (MET) to $95, down from $97, while maintaining an “In Line” rating on the stock. This update reflects a re-evaluation by the analyst firm, following recent financial presentations and other analyst revisions for the insurance giant. The article also notes other recent analyst actions on MetLife, indicating active re-assessment of the company’s valuation.